Screening before hepatitis C treatment
Screening is an in-depth laboratory and instrumental examination of a patient before starting treatment for hepatitis C.
Studies and analyses included in the screening:
-
RNA HCV high-quality
-
RNA HCV quantitative
-
Genotyping
-
Fibromax
-
Biochemical blood analysis: AST, ALT, alkaline phosphatase, GGTP, total and direct bilirubin, glucose, insulin, iron, ferritin, urea, creatinine and albumin
-
Prothrombin time + INR
-
General clinical blood test
-
General urinalysis
-
HCG (for women)
-
Examination of thyroid function (TSH, anti-TPO)
-
Cancer markers- AFP, CA19.9
-
Markers of autoimmune hepatitis- ANA, AMA-M2
-
Lung X-ray
-
Ultrasound of the abdominal cavity
-
ECG
-
Consultation with an ophthalmologist
-
EGDS